These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


238 related items for PubMed ID: 8900921

  • 1. Effect of cyclophosphamide on tumor cell sensitivity to the action of immunological effectors.
    Culo F, Marić M, Morović-Vergles J.
    In Vivo; 1995; 9(5):439-46. PubMed ID: 8900921
    [Abstract] [Full Text] [Related]

  • 2. Some advantages of curing mice bearing a large subcutaneous MOPC-315 tumor with a low dose rather than a high dose of cyclophosphamide.
    Mokyr MB, Dray S.
    Cancer Res; 1983 Jul; 43(7):3112-9. PubMed ID: 6850619
    [Abstract] [Full Text] [Related]

  • 3. Role of antitumor immunity in cyclophosphamide-induced rejection of subcutaneous nonpalpable MOPC-315 tumors.
    Mokyr MB, Hengst JC, Dray S.
    Cancer Res; 1982 Mar; 42(3):974-9. PubMed ID: 6977410
    [Abstract] [Full Text] [Related]

  • 4. Suppression of secondary cellular immunity to a tumor allograft by cyclophosphamide and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Einstein AB, Fass L, Fefer A.
    Cancer Res; 1975 Mar; 35(3):492-6. PubMed ID: 1078784
    [Abstract] [Full Text] [Related]

  • 5. Cyclophosphamide-induced immunologically mediated regression of a cyclophosphamide-resistant murine tumor: a consequence of eliminating precursor L3T4+ suppressor T-cells.
    Awwad M, North RJ.
    Cancer Res; 1989 Apr 01; 49(7):1649-54. PubMed ID: 2522344
    [Abstract] [Full Text] [Related]

  • 6. Regulation of the expression of adoptive tumor rejection immunity by recipient cyclophosphamide-sensitive cells.
    Boyer CM, Kreider JW, Bartlett GL.
    Cancer Res; 1982 Jun 01; 42(6):2211-5. PubMed ID: 7042079
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
    Proietti E, Greco G, Garrone B, Baccarini S, Mauri C, Venditti M, Carlei D, Belardelli F.
    J Clin Invest; 1998 Jan 15; 101(2):429-41. PubMed ID: 9435316
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Enhancement of sheep erythrocyte (SRBC)-induced pleurisy in non-sensitized mice by cyclophosphamide: demonstration of natural cell-mediated immune reactivity to SRBC.
    Yamamoto S, Higuchi Y, Teshima H.
    Immunology; 1982 Sep 15; 47(1):31-40. PubMed ID: 7118162
    [Abstract] [Full Text] [Related]

  • 15. Antitumor resistance activation in mice: can the immunological memory cells enhance resistance?
    Kazmin SD, Todor IN, Chekhun VF.
    J Exp Clin Cancer Res; 2005 Dec 15; 24(4):585-93. PubMed ID: 16471321
    [Abstract] [Full Text] [Related]

  • 16. Tumor regression in tumor-bearing mice by inoculations of immunogenic somatic hybrid cells in combination with cyclophosphamide.
    Tachibana T, Dei T.
    Tokai J Exp Clin Med; 1983 Dec 15; 8(5-6):455-63. PubMed ID: 6681341
    [Abstract] [Full Text] [Related]

  • 17. The effect of cyclophosphamide on immunological control mechanisms.
    Turk JL, Parker D, Cameron AE.
    Int J Tissue React; 1984 Dec 15; 6(3):205-11. PubMed ID: 6480267
    [Abstract] [Full Text] [Related]

  • 18. [Effect of preliminary administration of allogenic cells on transplantation immunity in mice receiving cyclophosphamide].
    Cherniakhovskaia IIu, Fontalin LN, Rubakova EI.
    Biull Eksp Biol Med; 1978 Feb 15; 85(2):192-4. PubMed ID: 564721
    [Abstract] [Full Text] [Related]

  • 19. Studies on induction and control of cell-mediated autoimmunity. I. Induction of "autoreactive" T lymphocytes in mice by cyclophosphamide.
    L'age-Stehr J, Diamantstein T.
    Eur J Immunol; 1978 Sep 15; 8(9):620-4. PubMed ID: 309398
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.